Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Solanidine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003132 AN005140 Untargeted Metabolomics on Mouse colonic mucosa Colonic mucosa Mouse University College Cork Other
ST003131 AN005136 Untargeted Metabolomics on mouse caecal contents Cecum Mouse University College Cork Other
ST003002 AN004931 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) Feces Human Sarcopenia Chinese University of Hong Kong GC/LC-MS
ST002977 AN004887 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002819 AN004591 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center Other
ST002536 AN004171 Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma Thyroid Human Cancer Broad Institute of MIT and Harvard LC-MS
ST002471 AN004033 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002470 AN004029 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002247 AN003670 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard LC-MS
ST002246 AN003666 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard LC-MS
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham and Women's Hospital LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002089 AN003411 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health LC-MS
ST002088 AN003407 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health LC-MS
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center LC-MS
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001749 AN002849 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin-Madison LC-MS
ST001639 AN002682 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health LC-MS
ST001515 AN002512 A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans Blood Human Obesity Translational Research Institute- AdventHealth Orlando LC-MS
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center LC-MS
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center LC-MS
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000899 AN001463 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center LC-MS
  logo